Prognosis

A prognosis is a prediction of the outcome of one’s disease. How likely is survival? Will the cancer come back? These are the big questions on most people’s minds after receiving a diagnosis of nasopharyngeal cancer. In general, there are several characteristics of the tumor that can inform a patient about their chances of being cured.

Factors That Affect Prognosis

Cancer Stage

This is the most important factor that affects a patient’s chance of being cured.

Type and Grade

Both the type and grade of the tumor determine the amount of treatment necessary and the ultimate prognosis.

Spread into Local Structures

Spread into large nerves, blood vessels, bones, or other structures can worsen prognosis.

Spread to Lymph Nodes

Spread to lymph nodes in the neck decreases the chance of cure, especially if there is evidence of cancer growth beyond the lymph node. Both the number and size of lymph nodes are also important; for example, a low number of small lymph nodes may not increase a patient’s risk significantly.

EBV DNA Levels

High levels of Epstein-Barr Virus DNA have been shown to carry a worse prognosis.

Giving a percentage of survival is extremely challenging because cancer research often looks at multiple types of cancer and may include a large range of patients who underwent a variety of treatments. While each of these factors discussed above contributes to one’s outcome, patients should have an individual discussion with their doctor to determine their overall prognosis. 

Survival Rates for Patients with Nasopharyngeal Cancer

Stage I

Estimated Disease-Specific Survival at 5 Years

78%

Estimated Disease-Specific Survival at 10 Years

63%

Stage II

Estimated Disease-Specific Survival at 5 Years

64%

Estimated Disease-Specific Survival at 10 Years

52%

Stage III

Estimated Disease-Specific Survival at 5 Years

60%

Estimated Disease-Specific Survival at 10 Years

46%

Stage IV

Estimated Disease-Specific Survival at 5 Years

47%

Estimated Disease-Specific Survival at 10 Years

37%

Disclaimer: Estimated Disease-Specific Survival is the percentage of people with a specific cancer who are alive at a given time point, such as five years after diagnosis. It excludes people who may have died from a disease other than their cancer. While these estimates from large national databases are helpful, it is important to remember that these broad statistics may not apply to one’s individual situation.

Continue to the Next Section